[Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D005117:Cardiac Complexes, Premature / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology; D010480:Perhexiline / Q000627:therapeutic use; D010919:Placebos; D011405:Propafenone; D011427:Propiophenones / Q000008:administration & dosage / Q000627:therapeutic use*; D011802:Quinidine / Q000627:therapeutic use
D010919:Placebos; D011427:Propiophenones; D011405:Propafenone; D011802:Quinidine; D010480:Perhexiline
O propafenon na disritmia ventricular da cardiopatia isquêmica. Estudo quantitativo pelo sistema Holter.